NEW YORK, Sept. 26 (GenomeWeb News) - VisiGen Biotechnologies said today that it has won a Phase 1 Small Business Innovation Research grant from the National Institute of Health's National Institute of General Medical Sciences to develop a new method for labeling DNA, RNA, and proteins.
...and receive Daily News bulletins.
Already have an account?Login Now.
The US Food and Drug Administration has approved Alnylam's RNAi-based therapy Onpattro, according to Stat News.
Harvard Medical School's Seth Cassel and Cigall Kadoch argue in a Baltimore Sun op-ed that the recent TAILORx trial shows the potential of genomic-based medicine.
Researchers in the UK are working on using gene drives to control malaria-carrying mosquitoes, the Telegraph reports.
In PLOS this week: genetic architecture mediating gene expression, metabolomic patterns in multiple myeloma, and more.